Indivior PLC
Change company Symbol lookup
Select an option...
INVVY Indivior PLC
DKNG Draftkings Inc
TXRH Texas Roadhouse Inc
BCCI Baristas Coffee Company Inc
GOLDX Gabelli Gold Fund Class AAA
BIGRX American Century Disciplined Core Value Fund Investor Class
XOM Exxon Mobil Corp
COLFF Colabor Group Inc
BIO Bio Rad Laboratories Inc
RLGY Realogy Holdings Corp
Go

Health Care : Pharmaceuticals | Small Cap Blend
Based in United Kingdom
Company profile

Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence (the Indivior Business). Its treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue and central nervous system (CNS) disorders/schizophrenia. Its products are Suboxone Film (buprenorphine and naloxone), Suboxone Tablet (buprenorphine and naloxone), and Subutex Tablet (buprenorphine). Its other products include RBP-6000 in ATRIGEL, RBP-7000 risperidone monthly depot, Arbaclofen placarbil for alcohol use disorder (AUD), Intranasal naloxone for treatment of opioid overdose and RBP-8000 cocaine esterase for cocaine intoxication. Its RBP-6000 buprenorphine monthly depot is developed for the treatment of opioid use disorder. Its RBP-7000 risperidone monthly depot is developed for treatment of schizophrenia.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Price
Delayed
$7.17
Day's Change
-0.1272 (-1.74%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.40
Day's Low
7.14
Volume
(Below Average)

Today's volume of 3,181 shares is on pace to be lower than INVVY's 10-day average volume of 8,570 shares.

3,181

Earnings information for INVVY is not available.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.